Albert Gianchetti is the founder of XyloCor Therapeutics. XyloCor Therapeutics has raised $108M in total funding. Latest round: Series B. Based in Wayne, USA.
Albert Gianchetti is the President and CEO of XyloCor Therapeutics, a biotech startup based in Wayne, Pennsylvania, developing gene therapies for advanced coronary artery disease. He led the company through its first clinical trial, completed in 2023, and has overseen multiple funding rounds, including a $41.9 million Series A and a $67.5 million Series B.
Full founder directory · Investor directory · Company funding database · Fundraising library